Table 1.
schizophrenia (N = 97) |
Healthy controls (N = 100) |
t/X2 | p | |
---|---|---|---|---|
t | p | |||
Age (year) | 39.88 ± 9.828 | 40.23 ± 6.82 | 0.293 | 0.770 |
Mito-CD4+/CD8+ | 1.70 ± 0.69 | 1.66 ± 0.72 | -0.392 | 0.696 |
Mito-CD3+CD4+ | 683.63 ± 291.91 | 843.13 ± 451.59 | 2.953 | 0.004** |
Mito-CD3+CD4+ (%) | 47.70 ± 77.31 | 37.92 ± 7.14 | -1.260 | 0.209 |
Mito-CD3+ | 1213.39 ± 434.46 | 1519.00 ± 743.50 | 3.535 | 0.001** |
Mito-CD3+ (%) | 85.13 ± 133.94 | 68.84 ± 7.93 | -1.214 | 0.226 |
Mito-CD3+CD8+ | 429.84 ± 191.52 | 557.25 ± 307.96 | 3.498 | 0.001** |
Mito-CD3+CD8+ (%) | 26.36 ± 7.46 | 25.51 ± 7.57 | -0.801 | 0.424 |
X2 | p | |||
Sex (male/female) | 51/46 | 61/39 | 1.424 | 0.252 |
Mito, Mitochondria.
**p<0.01. Data were presented in Mean ± SD.